About me
Chris currently leads process development for Satellite Bio’s drug products, which are allogeneic cellular therapies for patients with liver disease. Previously, Chris managed CMC for an HSC therapy in Ph1/2 trials at Magenta Therapeutics, and prior to that led preclinical development of a combination product for bone healing inidications at Bioventus. Chris holds BS and MS degrees in Biomedical Engineering from Worcester Polytechnic Institute and a PhD in Bioengineering from Georgia Institute of Technology.